Genes that are potential targets for therapeutic drugs against aggressive breast cancer have been discovered by Genome Institute of Singapore scientists. Out of the 1.5 million women diagnosed with breast cancer in the world annually, nearly one in seven of these is classified as triple negative. Patients with triple-negative breast cancer (TNBC) have tumours that are missing three important proteins that are found in other types of breast cancer. The ...Saturday, 27 July 2013
Scientists Discover New Drug Targets for Aggressive Breast Cancer
Genes that are potential targets for therapeutic drugs against aggressive breast cancer have been discovered by Genome Institute of Singapore scientists. Out of the 1.5 million women diagnosed with breast cancer in the world annually, nearly one in seven of these is classified as triple negative. Patients with triple-negative breast cancer (TNBC) have tumours that are missing three important proteins that are found in other types of breast cancer. The ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment